John R. Bethea, PhD

Affiliations: 
Neurological Surgery University of Miami Miller School of Medicine, Miami, FL, United States 
Google:
"John Bethea"
Mean distance: 18.84 (cluster 32)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Martynyuk T, Ricard J, Bracchi-Ricard V, et al. (2024) Mitigating sTNF/TNFR1 activation on VGluT2 + spinal cord interneurons improves immune function after mid-thoracic spinal cord injury. Brain, Behavior, and Immunity
Martynyuk T, Ricard J, Bracchi-Ricard V, et al. (2024) Mitigating sTNF/TNFR1 activation on VGluT2+ spinal cord interneurons improves immune function after mid-thoracic spinal cord injury. Biorxiv : the Preprint Server For Biology
Bracchi-Ricard V, Nguyen K, Ricci D, et al. (2023) Increased activity of IRE1 improves the clinical presentation of EAE. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 37: e23283
Bracchi-Ricard V, Nguyen K, Ricci D, et al. (2023) Increased activity of IRE1 improves the clinical presentation of EAE. Biorxiv : the Preprint Server For Biology
O'Reilly M, Mironets E, Saltos T, et al. (2021) Pharmacological inhibition of soluble tumor necrosis factor-alpha (sTNFα) 2 weeks after high thoracic spinal cord injury does not affect sympathetic hyperreflexia. Journal of Neurotrauma
Mironets E, Fischer R, Bracchi-Ricard V, et al. (2019) Attenuating neurogenic sympathetic hyperreflexia robustly improves antibacterial immunity after chronic spinal cord injury. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience
Murphy KL, Fischer R, Swanson KA, et al. (2019) Synaptic alterations and immune response are sexually dimorphic in a non-pertussis toxin model of experimental autoimmune encephalomyelitis. Experimental Neurology. 113061
Fischer R, Sendetski M, Del Rivero T, et al. (2019) TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes. Proceedings of the National Academy of Sciences of the United States of America
Fischer R, Padutsch T, Bracchi-Ricard V, et al. (2019) Exogenous activation of tumor necrosis factor receptor 2 promotes recovery from sensory and motor disease in a model of multiple sclerosis. Brain, Behavior, and Immunity
Gerald MJ, Bracchi-Ricard V, Ricard J, et al. (2019) Continuous infusion of an agonist of the tumor necrosis factor receptor 2 in the spinal cord improves recovery after traumatic contusive injury. Cns Neuroscience & Therapeutics
See more...